| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.081 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |